Note: Ingredients listed on restricted chemical lists
EC/CAS
220-120-9/2634-33-5
Name of the chemical
1,2-Benzisothiazol-3(2H)-one
Concentration
≥0.025-<0.03% 0.036% ≥0.00025-<0.0015%
EC/CAS
611-341-5/55965-84-9
Name of the chemical
Mixture of 5-chloro-2-methyl-2H- isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6)
Concentration
≥ 0.036 %
EC/CAS
247-500-7
Name of the chemical
Mixture of 5-Chloro-2-methyl-isothiazol-3(2H)-one and 2-methylisothiazol-3(2H)-one
Concentration
N/A
EC/CAS
220-239-6
Name of the chemical
Mixture of 5-Chloro-2-methyl-isothiazol-3(2H)-one and 2-methylisothiazol-3(2H)-one 2-Methyl-2H-isothiazol-3-one
Concentration
=100
General Information
Version
8 (replaces version 7
Revision date
2025-04-09
Product name
PENETRON LATEX
1.2.1 Relevant identified uses
Liquid Mortar Improver
1.2.2. Uses advised against
No further relevant information available
Icons in SDS
Company Information
company name
PENETRON HELLAS S.A
e-mail address of the competent person responsible for the Safety Data Sheet
info@penetron.gr
GHS Information
Signal word
Void
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No 1272/2008 [CLP] Classification of the substance or mixture
Hazard pictograms
Void
Signal word
Void
Hazard statements
Void
Additional information
EUH208 Contains Mixture of 5-chloro-2-methyl-2H-isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H- isothiazol-3-one (EINECS 220-239-6), 1,2-benzisothiazol-3(2H)-one. May produce an allergic reaction. EUH210 Safety data sheet available on request.
Results of PBT and vPvB assessment
The product does not contain ingredients that are considered either persistent, bioaccumulative and toxic (PBT) or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
PBT Substances
Not applicable
vPvB Substances
Not applicable Determination of endocrine-disrupting properties The product does not contain substances included in the list established in accordance with Article 59(1) of REACH for endocrine disrupting properties or has not been identified as having endocrine disrupting properties according to the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or higher than 0.1%. EN (Contd. on page 2) (Contd. of page 1) *
2.1 Classification of the substance or mixture
Classification according to Regulation EC No 1272/2008 CLP: This product does not meet the criteria for classification in any hazard class according to Regulation (EC) No 1272/2008 on classification, labelling and packaging of substances and mixtures.
